ANTI-CD19 MONOCLONAL ANTIBODIES: A NEW APPROACH TO LYMPHOMA THERAPY (REVIEW ARTICLE)

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NADDAFI FATEMEH; DAVAMI FATEMEH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: International Journal of Molecular and Cellular Medicine Year:2015 | Volume:4 | Issue:3 Page(s): 143-151

Download Full-Text

View:

284

Download:

238

Cites:

Information Journal Paper

Title

ANTI-CD19 MONOCLONAL ANTIBODIES: A NEW APPROACH TO LYMPHOMA THERAPY (REVIEW ARTICLE)

Author(s)

NADDAFI FATEMEH | DAVAMI FATEMEH | Issue Writer Certificate

Keywords

ANTI-CD19

MONOCLONAL ANTIBODIES

B-CELL LYMPHOMA

ANTI-CD19 SFV

BLINATUMUMAB

Abstract

CD19 is expressed on B- lineage cells and follicular dendritic cells and plays a key role in B cell malignancies and autoimmune diseases. Thus, it has been considered as potential target for several MONOCLONAL ANTIBODIES (mAbs). For decades, chemotherapy has been known as one of the major antitumor therapies eradicating high proliferative tumor cells. But, anti- CD19 mAbs developed for treating CD19- positive lymphomas and autoimmune diseases would rank among the most novel area of research and development in the pharmaceutical industry. Moreover, several anti- CD19 mAbs are currently being tested in various clinical trials and this review provides an overview of the research accomplished so far.

Cites

No record.

References

No record.

Cite

APA: Copy

NADDAFI, FATEMEH, & DAVAMI, FATEMEH. (2015). ANTI-CD19 MONOCLONAL ANTIBODIES: A NEW APPROACH TO LYMPHOMA THERAPY (REVIEW ARTICLE). INTERNATIONAL JOURNAL OF MOLECULAR AND CELLULAR MEDICINE, 4(3), 143-151. SID. https://sid.ir/paper/332133/en

Vancouver: Copy

NADDAFI FATEMEH, DAVAMI FATEMEH. ANTI-CD19 MONOCLONAL ANTIBODIES: A NEW APPROACH TO LYMPHOMA THERAPY (REVIEW ARTICLE). INTERNATIONAL JOURNAL OF MOLECULAR AND CELLULAR MEDICINE[Internet]. 2015;4(3):143-151. Available from: https://sid.ir/paper/332133/en

IEEE: Copy

FATEMEH NADDAFI, and FATEMEH DAVAMI, “ANTI-CD19 MONOCLONAL ANTIBODIES: A NEW APPROACH TO LYMPHOMA THERAPY (REVIEW ARTICLE),” INTERNATIONAL JOURNAL OF MOLECULAR AND CELLULAR MEDICINE, vol. 4, no. 3, pp. 143–151, 2015, [Online]. Available: https://sid.ir/paper/332133/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops